Silvan Türkcan

Silvan Türkcan is a Senior Research Analyst at JMP Securities LLC, with previous experience in equity research in biotech and pharma at UBS and Oppenheimer & Co. Inc. Silvan co-founded xbird, a medical AI company, and has a background in radiation oncology and cancer biology from Stanford University and Institut Pasteur. Türkcan holds a PhD in Biophysics from École Polytechnique and has a Master's in Engineering Physics from the Technical University of Munich.